An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013

Authors

Keywords

Journal

Volume 3, Issue Suppl 2, Pages P169

Publisher

Springer Nature

Online

2015-11-05

DOI

10.1186/2051-1426-3-s2-p169

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now